Black Rock Mining (ASX:BKT): A mouth-watering graphite play in Tanzania with a US$1.4bn NPV project
Black Rock Mining (ASX:BKT) is developing the Mahenge Graphite Project in Tanzania. It is hoping to capitalise on the hot…
Here are 4 awesome ASX retail stocks to buy in FY25 … and 4 to sell
Here are 4 ASX retail stocks to buy in FY25! Universal Store (ASX:UNI) Universal Store is most poised to…
Paladin Energy (ASX:PDN): This A$3.5bn uranium developer is set to benefit from the Surge Towards a Nuclear Future
Paladin Energy (ASX: PDN) is one of several uranium stocks that saw an upswing in 2023 – by over 50%…
Should I buy McDonalds shares (NYSE:MCD)? Here are 3 reasons why we’re McLoving it!
McDonalds (NYSE:MCD) really doesn’t need an introduction. It is the world’s largest and most famous restaurant chain. It typically benefits…
What does your company’s auditor do and here’s why you should care
Each and every ASX-listed company will have auditor. But what do they do? Why is it almost always one of…
BrainChip (ASX:BRN): An exciting AI stock with an immense opportunity ahead
BrainChip is one of just a very few AI stocks on ASX BrainChip (ASX:BRN) is one of a few companies…
Some say the Big 4 Banks are Too Expensive, but are they really?
‘The Big Four Banks are Too Expensive’, it is often asserted, both by retail investors and professional analysts alike. Australia’s…
Fortescue is reliant on iron ore demand from China, but is the party over?
Iron ore demand from China has been the driving force behind the global iron ore market for the past two…
Where to Next for Bitcoin? Here’s where the world’s most famous cryptocurrency might be headed in the next 12 months
Where to Next for Bitcoin? To say Bitcoin (BTC) has been on an interesting journey over the past few months…
The Guzman y Gomez ASX IPO gained over 35% on its first trading day – but will the hot run last?
The Guzman y Gomez ASX IPO was a spectacular success. After months of rumours, and a few weeks marketing (and…
Share buybacks: Are they a good sign or a waste of money?
Share buybacks are a controversial topic amongst investors. Some say it is a waste of money, others will welcome it…
AFT Pharmaceuticals (ASX:AFP): A gem of a dual-listed healthcare company
AFT Pharmaceuticals (ASX:AFP) may not spring to mind as the best company to have come out of New Zealand. Many…
Can Tabcorp’s nеw boss improve the stock’s dwindling odds?
Tabcorp (ASX: TAH) has had a dog of a year, with its share price dropping roughly 40% in the last…
The dream of Bitcoin ETFs on the ASX will soon become a reality, but here’s what investors need to know
For a long time, the concept of bitcoin ETFs has been little more than a pipedream, until the SEC finally…
Should I buy Apple shares from Australia? Can the US$3.3tn behemoth grow any further?
Investors asking themselves, ‘Should I buy Apple shares from Australia,’ are not just considering buying shares any company, but the…